Electronic Study for Anastrozole Pharmacovigilance Evaluation - E-SAFE
Study identifier:ARI-IPEP-0104
ClinicalTrials.gov identifier:NCT00558168
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Electronic Study for Anastrozole Pharmacovigilance Evaluation
Medical condition
Early Breast Cancer
Phase
-
Healthy volunteers
No
Study drug
-
Sex
Female
Actual Enrollment
1850
Study type
Observational
Age
N/A
Date
Study Start Date: 31 Jan 2004
Primary Completion Date: -
Study Completion Date: 31 Jul 2008
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 May 2025 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Nejdet Uskent
Kadir Has University Medical School
